The growth in this market is supported mainly by the increasing prevalence of chronic diseases (such as cancer and cardiovascular diseases), the growing number of ablation procedures performed, and the development of next-generation ablation products and technologies. Also, the rapidly growing geriatric population, increasing number of hospitals & ablation centers, and rising awareness related to ablation procedures are further driving the ablation technologies market.

Market Dynamics:

Emergence of next-generation ablation products and significant adoption of minimally invasive procedures coupled with increasing number of ablation procedures are the key factors driving the growth of the global ablation technologies market. Furthermore, the rapidly increasing aging population with higher risk of target diseases and increasing number of hospitals, surgical, and ablation centers are also fueling the market growth.

However, ongoing healthcare reforms in the U.S. and cost-containment measures adopted by various governments are the key factors limiting the growth of this market. In addition, products recalls as well as therapeutic challenges related to efficacy of ablation products are the key challenges faced by industry players in the global ablation technologies market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=791

Driver: Increasing number of ablation procedures

Minimally invasive alternatives involve less pain, less scarring, and offer a quicker recovery for patients. Moreover, these procedures are more economical as compared to traditional surgical procedures. Globally, the acceptance of minimally invasive surgeries is increasing as these procedures are safer and have lower mortality as well as complication rates as compared to open surgeries (Source: Stanford University Medical Center Research).

The number of minimally invasive cosmetic procedures in the U.S. increased from ~13.9 million procedures in 2014 to 14.2 million in 2015 (Source: American Society for Aesthetic Plastic Surgery). Ablation is one of the most frequently used minimally-invasive techniques for the treatment of various tumor, AF, and uterine fibroids. Thus, the increasing demand for minimally invasive surgical procedures support the ablation procedures to increase worldwide and is driving the growth of the market.

Restraint: Reuse and reprocessing of devices in developing countries

As per the FDA and EU guidelines, ablation catheters are labeled as single-use devices (SUDs). However, high per-unit cost of these devices and limited reimbursement has led to their reprocessing and reuse mainly in hospitals with budget constraints. The cost incurred by a hospital/surgical center for reprocessing and reuse is less than 10% as compared to the cost of a new ablation device, reducing the overall procedural cost by around 50%. Germany is among the key European countries which allows the reuse of SUDs (including ablation catheters), provided the devices are reprocessed as per the regulatory guidelines.

Key questions addressed in the report:

# What are the growth opportunities related to ablation technologies market across major regions in the future?
# Emerging countries have immense opportunities for the growth and adoption of ablation technologies products. Will this scenario continue in the next five years?
# What are the various ablation technologies product segments and their market share in the overall market?
# What are the new trends and advancements in the ablation technologies market?

North America will continue to dominate the ablation technologies market in 2021

The ablation technologies market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2016, North America dominated the global market, followed by Europe. Factors including the drastically growing geriatric population, increasing prevalence of target diseases such as CVD and cancer, and the increasing demand for minimally invasive procedures are driving the market for ablation technologies in North America.

Feel Free to Connect With Our Experts@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=791

The prominent players in the ablation technologies market are Medtronic plc (Ireland), Biosense Webster (US), St. Jude Medical (US), Boston Scientific Corporation (US), CONMED Corporation (US), AngioDynamics (US), AtriCure (US), Smith & Nephew (UK), and Olympus Corporation (Japan).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]